They're just sneakier about it
Oral tirzepatide is a daily pill that acts as a dual agonist for both the GLP-1 and GIP receptors, mimicking the bodys natural incretin hormones to enhance insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite
The post says patients with sensitive gastrointestinal systems, those over age 65, and those taking concurrent medications may benefit from a slower approach, and that a doctor may keep someone at the lower levels longer than the standard schedule
It means IVIM is one of the few willing to subject their approach to scientific scrutiny and publish the results for anyone to evaluate
Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis
Gratzl S, Rodriguez PJ, Cartwright BMG, Baker C, Do D, Stucky NL